<html>
<head>
<meta charset='utf-8'>
<title>Daily Biotech & Science Report (2026-01-02)</title>
<style>

             body { font-family: Arial, sans-serif; margin: 20px; background-color: #f4f4f4; }
             .container { max-width: 800px; margin: auto; background: #fff; padding: 20px; }
             h1, h2, h3 { color: #333; }
             .news-item, .paper-item { border: 1px solid #ddd; padding: 15px; margin-bottom: 15px; border-radius: 5px; background: #fafafa; }
             .source-date { font-size: 0.9em; color: #666; }
             a { color: #1a0dab; text-decoration: none; }
             a:hover { text-decoration: underline; }
         
</style>
</head>
<body>
<div class='container'>
<h1>Daily Biotech & Science Report (2026-01-02)</h1>
<h2>Biotech Industry & Market News</h2>
<div class='news-item'>
<h3>Best Wishes to GEN Readers in 2026</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-12-31</em></p>
<p>Dear GEN Readers: As we close 2025, I along with the entire GEN team want to wish all of you a happy, healthy, and successful new year. Thank you for your continuing […] The post Best Wishes to GEN Readers in 2026 appeared first on GEN - Genetic Engineering and Biotechnology News.</p>
<p><a href='https://www.genengnews.com/topics/translational-medicine/best-wishes-to-gen-readers-in-2026/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>AbbVie does T cell engager deal in China for Zelgen's DLL3-targeted drug</h3>
<p class='source-date'><em>Endpoints News • 2025-12-31</em></p>
<p>AbbVie began 2025 with a T cell engager deal in China, and it's ending the year with another one. The Chicago-area pharmaceutical giant is going to Zelgen Biopharmaceuticals for a clinical-stage T cell engager called ...</p>
<p><a href='https://endpoints.news/abbvie-does-t-cell-engager-deal-in-china-for-zelgens-dll3-targeted-drug/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Vanda wins FDA approval for motion sickness drug</h3>
<p class='source-date'><em>Endpoints News • 2025-12-31</em></p>
<p>Vanda Pharmaceuticals won FDA approval for what it says is the first new medicine for motion sickness in more than four decades. The oral drug, called Nereus, will be launched in the coming months, Vanda ...</p>
<p><a href='https://endpoints.news/vanda-wins-fda-approval-for-motion-sickness-drug/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>FDA rejects Corcept’s cortisol-targeting drug for Cushing’s syndrome</h3>
<p class='source-date'><em>Endpoints News • 2025-12-31</em></p>
<p>Corcept Therapeutics failed to secure US approval for its drug candidate as a hormonal disorder treatment. The FDA rejected Corcept’s selective cortisol modulator relacorilant for Cushing’s syndrome, according to a company</p>
<p><a href='https://endpoints.news/fda-rejects-corcepts-cortisol-targeting-drug-for-cushings-syndrome/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Biotech’s groove is back for 2026 as XBI surges on M&A and lower rates</h3>
<p class='source-date'><em>Endpoints News • 2025-12-30</em></p>
<p>Biotech executives and shareholders can breathe easier heading into the new year for the first time in nearly half a decade. The industry’s leaders will arrive at January’s JP Morgan Healthcare Conference riding a surge ...</p>
<p><a href='https://endpoints.news/biotechs-groove-is-back-for-2026-as-xbi-surges-on-ma-and-lower-rates/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Insilico caps the year with a soaring Hong Kong IPO</h3>
<p class='source-date'><em>Endpoints News • 2025-12-30</em></p>
<p>Insilico Medicine, one of the original AI-driven drug discoverers, has stuck the landing after four years of trying to go public. The 11-year-old drug developer on Tuesday raised gross proceeds of ...</p>
<p><a href='https://endpoints.news/insilico-caps-the-year-with-a-soaring-hong-kong-ipo/' target='_blank'>Read more</a></p>
</div>
<h2>Microbiome & Antimicrobials News</h2>
<p>No recent microbiome news available today.</p>
<hr>
<h2>Scientific Papers</h2>
<h3>Biotech & Microbiome Focus Papers</h3>
<div class='paper-item'>
<h4>Therapeutic application of fecal microbiota transplantation for neurological diseases: Exploring novel mechanisms and perspectives.</h4>
<p class='source-date'><em>Zhang Yue, Chen Liuyi, Jin Jiaqin et al. | Experimental neurology • 2025-12-30</em></p>
<p><strong>Abstract:</strong> Recently, fecal microbiota transplantation (FMT) has garnered widespread attention as an emerging therapeutic approach in the field of neurological disorders. In this study, we review the research progress of FMT in treating neurological disorders. First, the development, safety, and efficacy of ...</p>
<p><a href='https://doi.org/10.1016/j.expneurol.2025.115631' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Exploring Bacteriophages as Potential Tools for Combating Multi Drug-Resistant Klebsiella pneumoniae: Isolation, Characterization, Genomic Insights, and In Vitro Evaluation.</h4>
<p class='source-date'><em>Ali Rahma E, Abo-Senna Amal S M, El-Safty Rasha A S et al. | Microbial pathogenesis • 2025-12-30</em></p>
<p><strong>Abstract:</strong> Bacteriophages are promising alternatives to antibiotics for combating multidrug-resistant (MDR) pathogens such as Klebsiella pneumoniae, a major cause of hospital-acquired infections. In this study, two K. pneumoniae-specific phages, vB_Kpn_RAH1 and vB_Kpn_RAH2, were isolated from sewage using a...</p>
<p><a href='https://doi.org/10.1016/j.micpath.2025.108274' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Cutaneous infections caused by Pseudomonas aeruginosa. Clinical presentation, diagnosis and treatment.</h4>
<p class='source-date'><em>Hartmann D, Ibaceta Ayala J, Morgado-Carrasco D | Actas dermo-sifiliograficas • 2025-12-30</em></p>
<p><strong>Abstract:</strong> Pseudomonas aeruginosa is a gram-negative opportunistic bacillus of great relevance in dermatology due to its ability to cause a wide spectrum of skin infections. These infections can be characterized by a greenish discoloration and a distinctive odor and can range from mild signs, such as follic...</p>
<p><a href='https://doi.org/10.1016/j.ad.2025.104590' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Targeting microbial β-CAs: bridging in silico screening with in vitro validation.</h4>
<p class='source-date'><em>Tondo Anna Rita, Fantacuzzi Marialuigia, Carradori Simone et al. | Bioorganic & medicinal chemistry • 2025-12-27</em></p>
<p><strong>Abstract:</strong> Antimicrobial resistance (AMR) is one of the world's most pressing health problems and requires immediate action from the scientific community. Pseudomonas aeruginosa is a particularly concerning bacterium due to its high level of resistance, especially among hospitalized and immunocompromised in...</p>
<p><a href='https://doi.org/10.1016/j.bmc.2025.118542' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Electrochemical biosensors as emerging alternatives to conventional detection of pathogens and antibiotic-resistance determinants.</h4>
<p class='source-date'><em>Zieliński Wiktor, Grabowska Iwona | Talanta • 2025-12-27</em></p>
<p><strong>Abstract:</strong> Antibiotic resistance among microorganisms has emerged as a critical global health threat, undermining the effectiveness of existing treatments and leading to increased morbidity, mortality, and healthcare costs. The rapid evolution and spread of resistant strains demand urgent development of eff...</p>
<p><a href='https://doi.org/10.1016/j.talanta.2025.129323' target='_blank'>View Paper</a></p>
</div>
<h3>Synthetic & Molecular Biology Papers</h3>
<div class='paper-item'>
<h4>Role of ncRNAs in Neurological Disorders and Cardiovascular Diseases.</h4>
<p class='source-date'><em>Sajid Muhammad Imran, Khan Fatima Abid, Mohsin Hadia et al. | Experientia supplementum (2012) • 2026-01-01</em></p>
<p><strong>Abstract:</strong> For a long time, noncoding RNAs (ncRNAs) were considered irrelevant fragments of the genome, dismissed as genetic noise. However, recent breakthroughs have unveiled their crucial Role in regulating gene expression, influencing fundamental biological processes such as chromatin remodeling, epigene...</p>
<p><a href='https://doi.org/10.1007/978-3-032-06948-1_2' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Noncoding RNAs: The Not So "Junk" DNA Is the Blueprint of the Transcriptional Landscape of the RNA World.</h4>
<p class='source-date'><em>Ullah Mohammad Fahad | Experientia supplementum (2012) • 2026-01-01</em></p>
<p><strong>Abstract:</strong> In the past, the vast genomic DNA, encoding transcripts now known as noncoding RNAs were considered as "junk DNA." However, over the years, studies have demonstrated the critical roles of these noncoding RNAs in various biological functions, leading to a major transformation in our understanding ...</p>
<p><a href='https://doi.org/10.1007/978-3-032-06948-1_1' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Comprehensive Differential Gene Expression Analysis in Glioblastoma Using PyDESeq2: A Comparison with Normal Brain Tissue.</h4>
<p class='source-date'><em>Karanikolaos Panagiotis, Exarchos Themis P, Vlamos Panagiotis et al. | Advances in experimental medicine and biology • 2026-01-01</em></p>
<p><strong>Abstract:</strong> Glioblastoma multiforme (GBM) is a highly aggressive and heterogeneous brain tumor, characterized by poor prognosis and resistance to conventional therapies. Despite advances in multimodal treatment approaches, such as surgery, radiation, and chemotherapy, the prognosis for GBM remains poor, larg...</p>
<p><a href='https://doi.org/10.1007/978-3-032-03402-1_26' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Introducing D</h4>
<p class='source-date'><em>Papakonstantinou Eleni, Mylonas Theofilos, Papazidis George et al. | Advances in experimental medicine and biology • 2026-01-01</em></p>
<p><strong>Abstract:</strong> The rapid advancement in molecular biology and bioinformatics has enabled the development of sophisticated software tools for protein modeling and optimization. This chapter presents the development and application of a novel software suite, "D</p>
<p><a href='https://doi.org/10.1007/978-3-032-03402-1_38' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Bioinformatics Approaches in Noncoding RNAs Research.</h4>
<p class='source-date'><em>Khan Fariya, Kumar Ajay, Akhtar Salman | Experientia supplementum (2012) • 2026-01-01</em></p>
<p><strong>Abstract:</strong> In recent years, noncoding RNAs have sparked significant interest in understanding the diverse roles of ncRNAs in cellular regulation and disease processes. Noncoding RNAs (ncRNAs), encompassing small noncoding RNAs (sncRNAs) and long noncoding RNAs (lncRNAs), are critical regulators of gene expr...</p>
<p><a href='https://doi.org/10.1007/978-3-032-06948-1_13' target='_blank'>View Paper</a></p>
</div>
<h3>Bacteriophage Research Papers</h3>
<p>No recent papers on Bacteriophage Research available today.</p>
<h3>Skin Microbiome & Disease Papers</h3>
<div class='paper-item'>
<h4>Skin Microbiome Shifts Associated with Elevated Squamous Cell Carcinoma Risk.</h4>
<p class='source-date'><em>Saheb Kashaf Sara, Higuchi Hiroshi, Han Jungmin et al. | The Journal of investigative dermatology • 2026-01-01</em></p>
<p><strong>Abstract:</strong> No abstract available</p>
<p><a href='https://doi.org/10.1016/j.jid.2025.06.1590' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Translating Geroscience Into Clinical Longevity Dermatology: From Mechanisms of Aging to Skin-Centered Interventions.</h4>
<p class='source-date'><em>Haykal Diala | Journal of cosmetic dermatology • 2026-01-01</em></p>
<p><strong>Abstract:</strong> BACKGROUND: Longevity medicine is an emerging clinical framework aimed at extending healthspan by targeting the biological mechanisms of aging rather than treating disease in isolation. Geroscience, which investigates the molecular and cellular pathways linking aging to chronic pathology, provide...</p>
<p><a href='https://doi.org/10.1111/jocd.70616' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Climate Change and Infectious Diseases in Dermatology.</h4>
<p class='source-date'><em>Belzer Annika, Coates Sarah J | Dermatologic clinics • 2026-01-01</em></p>
<p><strong>Abstract:</strong> Human activities have led to climate change, resulting in global warming, ocean warming, and more frequent extreme weather events (EWEs). Each of these has the potential to amplify infectious diseases with skin manifestations. Alterations in the skin microbiome due to rising temperatures and humi...</p>
<p><a href='https://doi.org/10.1016/j.det.2025.08.003' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Dysbiosis in Acne Vulgaris and Hidradenitis Suppurativa: A Comparative Microbiome Analysis.</h4>
<p class='source-date'><em>Chen Wanxin, Lai Xiaodong, Tang Xin et al. | Experimental dermatology • 2026-01-01</em></p>
<p><strong>Abstract:</strong> Acne and hidradenitis suppurativa (HS) are inflammatory disorders of the pilosebaceous unit that exhibit distinct clinical manifestations, indicating that they likely differ in their underlying pathophysiology. Microbial dysbiosis is implicated in both diseases, yet direct comparisons using unifi...</p>
<p><a href='https://doi.org/10.1111/exd.70198' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Activity of cloxacillin against </h4>
<p class='source-date'><em>Angelopoulou Alkmini, Riff Alexandersen Nicolai, Salgaard Jensen Christian et al. | Infectious diseases (London, England) • 2026-01-01</em></p>
<p><strong>Abstract:</strong> BACKGROUND:  OBJECTIVE: We aimed to compare MIC distributions of  METHODS: We evaluated the  RESULTS: All isolates were susceptible to benzylpenicillin (MIC ≤0.064 mg/L) and cloxacillin (MIC ≤0.5 mg/L), with MIC CONCLUSION: Our findings indicate that intravenous cloxacillin is an effective treatm...</p>
<p><a href='https://doi.org/10.1080/23744235.2025.2589921' target='_blank'>View Paper</a></p>
</div>
<hr>
<p><em>Report generated on 2026-01-02</em></p>
</div>
</body>
</html>